{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:41:06Z","timestamp":1767962466620,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":2776,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1074\/mcp.m112.019786","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T21:10:49Z","timestamp":1353532249000},"page":"381-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Proteomic Profiling of Triple-negative Breast Carcinomas in Combination With a Three-tier Orthogonal Technology Approach Identifies Mage-A4 as Potential Therapeutic Target in Estrogen Receptor Negative Breast Cancer"],"prefix":"10.1016","volume":"12","author":[{"given":"Teresa","family":"Cabez\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Gromova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Gromov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Timmermans Wielenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Kroman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio E.","family":"Celis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M112.019786_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.2001.19.1.18","article-title":"Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database","volume":"19","author":"Anderson","year":"2011","journal-title":"J. Clin. Oncol"},{"issue":"Suppl 1","key":"10.1074\/mcp.M112.019786_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.11-90001-4","article-title":"Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer","volume":"11","author":"Baselga","year":"2006","journal-title":"Oncologist"},{"key":"10.1074\/mcp.M112.019786_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1016361932220","article-title":"Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial\/ethnic groups","volume":"74","author":"Chu","year":"2002","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1074\/mcp.M112.019786_bib4","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1158\/1078-0432.CCR-09-0636","article-title":"Resistance to trastuzumab in breast cancer","volume":"15","author":"Pohlmann","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.M112.019786_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists","volume":"24","author":"Badve","year":"2011","journal-title":"Mod. Pathol"},{"key":"10.1074\/mcp.M112.019786_bib7","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"Anders","year":"2009","journal-title":"Clin. Breast Cancer"},{"key":"10.1074\/mcp.M112.019786_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10147-010-0106-1","article-title":"Clinicopathological features and treatment strategy for triple-negative breast cancer","volume":"15","author":"Yamamoto","year":"2010","journal-title":"Int. J. Clin. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib9","first-page":"1","article-title":"The cancer\/testis genes: review, standardization, and commentary","volume":"4","author":"Scanlan","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1074\/mcp.M112.019786_bib10","doi-asserted-by":"crossref","first-page":"18066","DOI":"10.1073\/pnas.0608853103","article-title":"Characterization of a cancer\/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients","volume":"103","author":"Parmigiani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M112.019786_bib11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1074\/mcp.M112.019786_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M112.019786_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3816\/CLC.2009.n.052","article-title":"MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy","volume":"10","author":"Tyagi","year":"2009","journal-title":"Clin. Lung Cancer"},{"key":"10.1074\/mcp.M112.019786_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molonc.2011.02.001","article-title":"The biology of cancer testis antigens: putative function, regulation and therapeutic potential","volume":"5","author":"Fratta","year":"2011","journal-title":"Mol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-065X.2002.18806.x","article-title":"Tumor-specific shared antigenic peptides recognized by human T cells","volume":"188","author":"van der","year":"2002","journal-title":"Immunol. Rev"},{"key":"10.1074\/mcp.M112.019786_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/modpathol.3880078","article-title":"Immunoreactivity with the anti-Mage antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters","volume":"13","author":"Busam","year":"2000","journal-title":"Mod. Pathol"},{"key":"10.1074\/mcp.M112.019786_bib17","first-page":"32","article-title":"Expression and possible prognostic role of Mage-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study","volume":"47","author":"Bandi\u0107","year":"2006","journal-title":"Croat. Med. J"},{"key":"10.1074\/mcp.M112.019786_bib18","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/S0021-9258(19)41496-8","article-title":"High resolution two-dimensional electrophoresis of proteins","volume":"250","author":"O'Farrell","year":"1975","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M112.019786_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molonc.2008.09.003","article-title":"A single lysis solution for the analysis of tissue samples by different proteomic technologies","volume":"2","author":"Gromov","year":"2008","journal-title":"Mol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004280050226","article-title":"Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas","volume":"433","author":"Malzahn","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1074\/mcp.M112.019786_bib21","series-title":"Cell Biology. A Laboratory Handbook","article-title":"Gel-based proteomics: High-resolution two-dimensional gel electrophoresis of proteins. Isoelectric focusing (IEF) and nonequilibrium pH gradient electrophoresis (NEPHGE)","volume":"Vol. 4","author":"Celis","year":"2004"},{"key":"10.1074\/mcp.M112.019786_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molonc.2009.11.003","article-title":"Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast","volume":"4","author":"Gromov","year":"2010","journal-title":"Mol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1074\/mcp.M500348-MCP200","article-title":"Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype","volume":"5","author":"Celis","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.019786_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molonc.2010.09.005","article-title":"Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy","volume":"4","author":"Moreira","year":"2010","journal-title":"Mol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.molonc.2009.01.005","article-title":"Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort","volume":"3","author":"Celis","year":"2009","journal-title":"Mol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0192623311419163","article-title":"The use of immunohistochemistry for biomarker assessment\u2013can it compete with other technologies?","volume":"39","author":"Dunstan","year":"2011","journal-title":"Toxicol. Pathol"},{"key":"10.1074\/mcp.M112.019786_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2559.2006.02513.x","article-title":"Quantification of immunohistochemistry\u2013issues concerning methods, utility and semiquantitative assessment II","volume":"49","author":"Taylor","year":"2006","journal-title":"Histopathology"},{"key":"10.1074\/mcp.M112.019786_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2559.2006.02514.x","article-title":"Quantification of immunohistochemistry\u2013issues concerning methods, utility and semiquantitative assessment I","volume":"49","author":"Walker","year":"2006","journal-title":"Histopathology"},{"key":"10.1074\/mcp.M112.019786_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/CCO.0b013e32834bf8ae","article-title":"Molecular heterogeneity of triple-negative breast cancer and its clinical implications","volume":"23","author":"Irshad","year":"2011","journal-title":"Curr. Opin. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib30","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1074\/mcp.R800011-MCP200","article-title":"15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma","volume":"7","author":"Celis","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1074\/mcp.M112.019786_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O","article-title":"The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma","volume":"29","author":"Balleine","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1074\/mcp.M112.019786_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.vaccine.2009.01.089","article-title":"Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival","volume":"27","author":"Mirshahidi","year":"2009","journal-title":"Vaccine"},{"key":"10.1074\/mcp.M112.019786_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00262-007-0416-y","article-title":"Vaccination with metastasis-related tumor associated antigen TPD52 and CpG\/ODN induces protective tumor immunity","volume":"57","author":"Payton","year":"2008","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1074\/mcp.M112.019786_bib34","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1158\/1078-0432.CCR-07-4994","article-title":"Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52","volume":"14","author":"Shehata","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1074\/mcp.M112.019786_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.M112.019786_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/548.6505","article-title":"Triple-negative breast cancer: current state of the art","volume":"96","author":"Rastelli","year":"2010","journal-title":"Tumori"},{"key":"10.1074\/mcp.M112.019786_bib38","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1158\/1078-0432.CCR-06-0527","article-title":"Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma","volume":"12","author":"Sharma","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib39","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-05-3327","article-title":"Melanoma antigen A4 is expressed in nonsmall cell lung cancers and promotes apoptosis","volume":"66","author":"Peikert","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib40","first-page":"1287","article-title":"Mage-A4, a germ cell specific marker, is expressed differentially in testicular tumors","volume":"168","author":"Richie","year":"2002","journal-title":"J. Urol"},{"key":"10.1074\/mcp.M112.019786_bib41","first-page":"6682","article-title":"Mage-A gene expression pattern in primary breast cancer","volume":"61","author":"Otte","year":"2001","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/modpathol.3800232","article-title":"Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray","volume":"18","author":"Chitale","year":"2005","journal-title":"Mod. Pathol"},{"key":"10.1074\/mcp.M112.019786_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/annonc\/mdq325","article-title":"Cancer-testis antigen expression in triple-negative breast cancer","volume":"22","author":"Curigliano","year":"2011","journal-title":"Ann. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib44","article-title":"Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation","author":"Karn","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib45","doi-asserted-by":"crossref","first-page":"e17876","DOI":"10.1371\/journal.pone.0017876","article-title":"Multiple cancer\/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers","volume":"18","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M112.019786_bib46","first-page":"32","article-title":"Expression and possible prognostic role of Mage-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study","volume":"47","author":"Bandi\u0107","year":"2006","journal-title":"Croat. Med. J"},{"key":"10.1074\/mcp.M112.019786_bib47","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1073\/pnas.0906840106","article-title":"CT-X antigen expression in human breast cancer","volume":"106","author":"Grigoriadis","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M112.019786_bib48","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.24296","article-title":"Cancer\/testis antigen CT45: analysis of mRNA and protein expression in human cancer","volume":"124","author":"Chen","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib49","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00262-011-1005-7","article-title":"Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?","volume":"60","author":"Adams","year":"2011","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1074\/mcp.M112.019786_bib50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<749::AID-IJC24>3.0.CO;2-O","article-title":"Anti-Mage-3antibody 57B and anti-Mage-1 antibody 6C1 can be used to study different proteins of the Mage-A family","volume":"86","author":"Rimoldi","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.169.1.575","article-title":"Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by Mage-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy","volume":"169","author":"Graff-Dubois","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M112.019786_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.26074","article-title":"Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination","volume":"130","author":"Kawada","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib53","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1158\/1078-0432.CCR-11-1873","article-title":"Improving T cell therapy for relapsed EBV negative Hodgkins Lymphoma by targeting upregulated Mage-A4","volume":"17","author":"Cruz","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1349-7006.2011.02111.x","article-title":"TCR gene therapy targeting Mage-A4 inhibits human tumor growth in NOD\/SCID\/\u03b3c(null) mice","volume":"103","author":"Shirakura","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1074\/mcp.M112.019786_bib55","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N","article-title":"Monoclonal antibody 57B stains tumor tissues that express gene Mage-A4","volume":"86","author":"Landry","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib56","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1021\/pr800364d","article-title":"Immobilized metal affinity chromatography revisited: pH\/acid control toward high selectivity in phosphoproteomics","volume":"7","author":"Tsai","year":"2008","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M112.019786_bib57","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/ac901764g","article-title":"Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer","volume":"82","author":"Raijmakers","year":"2010","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M112.019786_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and quantitative assessment of the ubiquitin-modified proteome","volume":"44","author":"Kim","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.M112.019786_bib59","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1074\/jbc.M310437200","article-title":"A cleaved form of Mage-A4 binds to Miz-1 and induces apoptosis in human cells","volume":"279","author":"Sakurai","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M112.019786_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1074\/mcp.R300007-MCP200","article-title":"Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research","volume":"2","author":"Celis","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.019786_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004280100421","article-title":"Expression of Mage tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study","volume":"439","author":"Kavalar","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1074\/mcp.M112.019786_bib62","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","article-title":"on behalf of the TRANSBIG Consortium (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series","volume":"13","author":"Desmedt","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1074\/mcp.M400009-MCP200","article-title":"Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery","volume":"3","author":"Celis","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.019786_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1126\/scitranslmed.3003110","article-title":"Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations","volume":"3","author":"Hori","year":"2011","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/mcp.M112.019786_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<287::AID-IJC7>3.0.CO;2-T","article-title":"Detection of Mage-4 protein in sera of patients with head-and-neck squamous-cell carcinoma","volume":"70","author":"Iwamoto","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/gyno.1999.5701","article-title":"Serum Mage-4 protein in ovarian cancer patients","volume":"76","author":"Kawagoe","year":"2000","journal-title":"Gynecol. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(95)00145-Z","article-title":"Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular Mage-4 protein on human cancers","volume":"186","author":"Shichijo","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/mcp.M112.019786_bib68","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1349-7006.1997.tb00469.x","article-title":"Detection of Mage-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis","volume":"88","author":"Tsuzurahara","year":"1997","journal-title":"Jpn. J. Cancer Res"},{"key":"10.1074\/mcp.M112.019786_bib69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ijc.2910640303","article-title":"Detection of MAGE-4 protein in lung cancers","volume":"64","author":"Shichijo","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M112.019786_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-010-1135-1","article-title":"The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer","volume":"124","author":"Gabos","year":"2010","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1074\/mcp.M112.019786_bib71","first-page":"1419","article-title":"Danish Breast Cancer Cooperative Group","volume":"26","author":"Kyndi","year":"2008","journal-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group, J. Clin. Oncol"},{"key":"10.1074\/mcp.M112.019786_bib72","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-011-1669-4","article-title":"The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy","volume":"18","author":"Zaky","year":"2011","journal-title":"Ann. Surg. Oncol"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620332503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620332503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M112.019786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:46:54Z","timestamp":1761526014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620332503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1535947620332503"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m112.019786","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic Profiling of Triple-negative Breast Carcinomas in Combination With a Three-tier Orthogonal Technology Approach Identifies Mage-A4 as Potential Therapeutic Target in Estrogen Receptor Negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M112.019786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}